Profil
Ronnie Wallin is the founder of Galenica AB, where he holds the title of Chief Executive Officer & Director since 1999.
He is currently a Director at Medeon AB.
Postes actifs de Ronnie Wallin
Sociétés | Poste | Début |
---|---|---|
Galenica AB
Galenica AB Pharmaceuticals: MajorHealth Technology Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden. | Fondateur | 01/01/1999 |
Medeon AB
Medeon AB Miscellaneous Commercial ServicesCommercial Services Medeon AB is a life science research park located in Malmö, Sweden. The Swedish company offers various services such as incubation, office and conference spaces, and laboratory facilities to its partner companies. Medeon focuses on several areas of research, including diabetes, nanomedicine, and pharma development. The private company has a diverse range of partner companies, including Ascelia Pharma, Biora AB/Straumann, and Gordiamkey. The CEO of the company is Ulf G. Andersson. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Galenica AB
Galenica AB Pharmaceuticals: MajorHealth Technology Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden. | Health Technology |
Medeon AB
Medeon AB Miscellaneous Commercial ServicesCommercial Services Medeon AB is a life science research park located in Malmö, Sweden. The Swedish company offers various services such as incubation, office and conference spaces, and laboratory facilities to its partner companies. Medeon focuses on several areas of research, including diabetes, nanomedicine, and pharma development. The private company has a diverse range of partner companies, including Ascelia Pharma, Biora AB/Straumann, and Gordiamkey. The CEO of the company is Ulf G. Andersson. | Commercial Services |